Over the years, the role of CCR9/CCL25 in inflammation and related diseases has become increasingly clearness, including cardiovascular disease (CVD), hepatitis, arthritis (Yokoyama et al., 2014), inflammatory bowel disease (Kalindjian et al., 2016), and asthma. This evidence concerns the gene CCL25 and hepatitis A virus infection.